AzTrials
AzTrials

Communication BarriersBruWNedNCT06700980

Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens

An observational study of Communication Barriers and Language, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this qualitative study is to find out which technological translation tools can be used to improve Dutch-speaking care in all Brussels out-of-hours primary care services. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Focus Group
How many people
40 participants
Where
1 siteBelgium
Study dates
10 Dec 2024to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Dutch-speaking residents of Brussels Primary care physicians of Brussels Representatives from pertinent organizational and policy sectors of Belgium

Who may be able to join

  • Patients: adult, living in Brussels, Dutch-speaking
  • GPs: adult, working in Brussels, Dutch- and/or French-speaking
  • Employees of professional organization-regulatory bodies: adult, Dutch-and/or French-speaking

Who cannot join

  • Subject is not capable of will
  • Subject cannot express themself in Dutch or French

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Prof. Dr. A. Roex contact

ann.roex@vub.be

Belgium1 site, 1 recruiting
  • Vrije Universiteit Brussel

    Jette, Brussels Capital, 1090

    Recruiting

Other trials in Belgium

About this study

The purpose of this qualitative study is to find out which technological translation tools can be used to improve Dutch-speaking care in all Brussels out-of-hours primary care services.

Read the detailed description

Previous studies have shown that language barriers in healthcare can lead to communication problems between healthcare provider and patient. This can lead to a decrease in satisfaction, quality of care and patient safety. Dutch speakers are a minority in Brussels (a Dutch-French bilingual region in Belgium), and the majority of general practitioners (GPs) in the Brussels out-of-hours primary care services are French-speaking. Measures are already being taken to increase the number of bilingual (Dutch and French) GPs.

In addition, several technological tools (e.g. video interpreting, translation apps, ...) exist to overcome language barriers. The investigators want to explore which of these options can be used in Brussels out-of-hours primary care services to improve access for Dutch-speaking citizens. The objective of this study is to examine both barriers and facilitators to use these technological translation tools during language-discordant consultations with a French-speaking GP and a Dutch-speaking patient in Brussels out-of-hours primary care services.

To achieve this objective, the investigators aim to engage Dutch-speaking patients, Dutch- and/or French-speaking GPs, as well as Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors.

There will be about 40 participants in total. Participants will answer questions during an online group session (focus group). There will be 4 focus groups, with a maximum of 10 participants in each focus group. Each focus group will last 60-90 minutes.

Being tested
Focus Group
Keywords
Language barrier, translation, healthcare, technological tool, Official language minority
Medical subject headings
Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focus GroupOther

    Dutch-speaking patients, Dutch- and/or French-speaking general practitioners and Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors will be questioned in heterogeneous focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.

Study groups in NCT06700980
Study groupRoleWhat they receive
Focus GroupFour groups of participants will meet for online focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
Receives: Other: Focus Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exploration of barriers and facilitators of different stakeholders to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.

    Focus group results will provide a list of barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.

    Measured: The outcome will be measured during the online focus group, which will have a duration of 60 to 90 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2024
  2. Study start10 Dec 2024
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06700980
Sponsor's protocol ID
24366_BruWNed
Acronym
BruWNed
Status last verified
Dec 2024
First submitted
7 Nov 2024
Last updated
27 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Communication Barriers and Language, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aurore Torsin (+32 2 477 41 02, aurore.torsin@vub.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exploration of barriers and facilitators of different stakeholders to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners. (time frame: The outcome will be measured during the online focus group, which will have a duration of 60 to 90 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in